Skip to main content

What the FDA labels say about taking them together

Fesoterodine and verapamil

Fesoterodine's FDA label of April 7, 2026 names verapamil in its drug interactions section; the verapamil labels PlainMeds reads (4) do not name fesoterodine. The fesoterodine label: “No dosing adjustments are recommended in the presence of moderate CYP3A4 inhibitors.”

Check it at the source: the fesoterodine FDA label on DailyMed (effective April 7, 2026, Pfizer Laboratories Div Pfizer Inc); the verapamil FDA label on DailyMed (effective April 6, 2026, Zydus Pharmaceuticals (USA) Inc.).

What does the fesoterodine label say about verapamil?

Fesoterodine label, drug interactions

No dosing adjustments are recommended in the presence of moderate CYP3A4 inhibitors (e.g., erythromycin, fluconazole, diltiazem, verapamil and grapefruit juice).

Source: FDA drug label (Toviaz), Pfizer Laboratories Div Pfizer Inc, effective April 7, 2026 (SPL set 5be745f0-8ae7-4c3c-9962-37d6263326f1), via openFDA; the full label on DailyMed

What does the verapamil label say about fesoterodine?

Verapamil's label (effective April 6, 2026) and its 3 other brand-application labels do not name fesoterodine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Verapamil hydrochloride), Zydus Pharmaceuticals (USA) Inc., effective April 6, 2026 (SPL set e19ab8d8-dae5-489d-9805-7e7407bea06d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Fesoterodine generic labelers
43Verapamil generic labelers
FesoterodineVerapamil
Labeled forOveractive bladderHigh blood pressure, Atrial fibrillation, Angina
Boxed warningNoNo
Pharmacy cost (NADAC)$0.794 per tablet 4 mg tablet$0.191 per tablet 180 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?